Company Financials

Suzhou Zelgen Biopharmaceuticals Co. Ltd Financials

Renminbi

business Suzhou Zelgen Biopharmaceuticals Co. Ltd Company Profile

Main Stock Listing

SSE: 688266

Market Capitalization CN¥30.72 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE -222.37
Forward PE -93.59
Price to Sales TTM CN¥51.86
Price to Book MRQ CN¥25.05
Enterprise to Revenue 46.13
Enterprise to EBITDA -172.39

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin -21.37%
Operating Margin -24.00%
Return on Assets TTM -4.19%
Return on Equity TTM -9.56%

Income Statement

Revenue TTM CN¥592,351,936
Revenue per Share TTM CN¥2.25
Quarterly Revenue Growth 54.90%
Gross Profit TTM CN¥542,308,544
EBITDA CN¥-158,507,760
Net Income to Common TTM CN¥-126,593,624
Diluted EPS TTM CN¥-0.48
Quarterly Earnings Growth YoY 54.87%

Balance Sheet

Total Cash MRQ CN¥2,136,563,712
Total Cash per Share MRQ CN¥8.07
Total Debt MRQ CN¥
Total Debt to Equity MRQ 82.07
Current Ratio MRQ 1.88
Book Value per Share MRQ CN¥4.63

Cash Flow

Operating Cash Flow TTM CN¥-57,072,476
Levered Free Cash Flow TTM CN¥-79,336,048

688266 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 264,708,186
Float Shares 151,815,439
Avg 10 Volume 3,724,424
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 30.21%
% Held by Institutions 38.09%

Stock Price Summary

Beta 0.32
Fifty Two Week Low CN¥49.00
Fifty Two Week High CN¥125.99
Fifty Two Week Change 55.06%
Day 50 MA CN¥106.18
Day 200 MA CN¥81.00

Dividends and Splits

Forward Annual Dividend Rate CN¥
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate CN¥0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date